1. Background {#sec1}
=============

An estimated one-third of the world\'s population is infected with tuberculosis (TB) \[[@B1]\]. The human immunodeficiency virus (HIV) pandemic has resulted in dramatic increases in TB case notification rates, particularly in resource-limited settings \[[@B2]\]. This is because people living with HIV have a much greater risk of developing active TB than HIV-uninfected individuals \[[@B3]\]. South Africa is one of the countries most heavily affected by the dual HIV and TB epidemics \[[@B4]\], with an estimated 31% of all global TB cases occurring among HIV-positive individuals \[[@B5]\]. For example, in Gugulethu, a township in Cape Town, over half of antiretroviral therapy (ART) clinic attendees had previously been treated for TB, one-quarter were diagnosed with active TB, and a further 10% developed TB during the first year following initiation onto lifelong ART \[[@B6]\].

In resource-limited settings, where the majority of HIV-TB cases occur, TB diagnostics are frequently limited to sputum smear microscopy, despite the increased likelihood of smear negative disease among immunosuppressed patients \[[@B7]\]. This scenario complicates TB diagnosis and frequently results in delay in TB diagnosis in HIV-infected patients \[[@B8]\]. This delayed detection often leads to increased mortality and treatment complications for patients \[[@B9]\]. In addition, undiagnosed TB in patients starting ART may result in symptomatic immune reconstitution inflammatory syndrome during early ART phase because of unmasking of TB disease by ART \[[@B10]\]. We have previously reported on high mortality due to TB among ART initiators in this community \[[@B11]\]. Reducing delays in PTB diagnosis could improve patients\' health outcomes and minimise public risk of exposure to TB in the community. The purpose of this study was to investigate factors associated with the delay in TB diagnosis among HIV patients following entry into public sector HIV services in rural South Africa.

2. Methods {#sec2}
==========

2.1. Study Setting {#sec2.1}
------------------

This study was conducted at Rixile Clinic, a dedicated nongovernmental-organisation-(NGO-) supported, rural HIV clinic situated at Tintswalo hospital in Bushbuckridge, Mpumalanga, South Africa. Three HIV-trained doctors and six primary health care nurses provide comprehensive care for HIV patients at the clinic, including provision of ART, and screening for and management of TB, opportunistic infections, and sexually transmitted infections. The clinic was accredited for provision of ART in October 2005. Since then more than 2,000 individuals have been initiated on ART. Bushbuckridge is a densely populated rural area with a population of approximately 600,000 people living in 133 villages. The region is one of 13 rural nodal areas of extreme poverty in South Africa.

2.2. Study Design {#sec2.2}
-----------------

This was a retrospective cohort study of PTB suspects at Rixile Clinic. Data were extracted from the ART clinic records of patients identified as PTB suspects from the PTB suspects register over a two-year period from January 2006 to December 2007.

2.3. Study Population {#sec2.3}
---------------------

The study population was comprised of adults (18 years and older) at the time of identification as a PTB suspect and with confirmed HIV infection. All patients had attended the Rixile clinic at least once. PTB suspects were defined as patients who were provided with sputum jars for Acid-Fast Bacilli screening for PTB.

2.4. Data Collection and Management {#sec2.4}
-----------------------------------

Trained research assistants extracted data from the PTB suspects register and from patients\' ART clinic medical records using a structured data collection tool. Data were abstracted on the following variables: sociodemographic factors, presenting symptoms, timing, and results of TB investigations, diagnosis category, date and regimen of TB treatment initiated, and details of HIV treatment, including ART initiation. Data were double-entered into Epi info version 3.5.1 (CDC, Atlanta, USA). Statistical analyses were conducted using STATA version 11 (Statacorp, College Station, USA).

2.5. Definition of TB Diagnosis Delay {#sec2.5}
-------------------------------------

TB diagnostic delay was defined as any diagnosis taking longer than 56 days from the time of requesting the first sputum examination. Although this definition is unconventional, it allows for the time required to complete all diagnostic examinations, including sputum culture, which is routinely requested among HIV-positive TB suspects with smear-negative results attending services at Rixile HIV clinic \[[@B12]\].

2.6. Statistical Analysis {#sec2.6}
-------------------------

Frequency distributions were used to describe categorical variables, and medians and interquartile ranges were used for continuous variables. The dependent variable diagnosis delay was categorized as a dichotomous variable (delay or nodelay). Bivariate associations were described using Chi-square tests. Variables that demonstrated significant association (*P* ≤ 0.1) with TB diagnosis delay were entered into a multivariate Cox proportional hazards regression model.

2.7. Ethical Consideration {#sec2.7}
--------------------------

Ethical approval for the study was obtained from the University of Witwatersrand Human Research Ethics Committee. Individual informed consent was not undertaken as the study used routinely collected clinic data.

3. Results {#sec3}
==========

In the two-year study period, 630 individuals were identified as PTB suspects and recorded in the PTB suspect register. Sixty-two were excluded for the following reasons: 4 were younger than 18 years old, 42 did not return their sputum jars and did not attend any subsequent review, 1 had extra pulmonary TB, and there was no information on the outcome of TB diagnosis for 15 patients. Eighty-five patients\' medical records were missing and 31 were duplicates. Thus, a total of 452 PTB suspects were included in the study. [Figure 1](#fig1){ref-type="fig"} summarizes the patients\' inclusion cascade.

The demographic information of the 452 patients included in the preliminary analysis is summarized in [Table 1](#tab1){ref-type="table"}. The ages of the patients ranged from 23 to 96 years old with a median age of 41 years (interquartile range (IQR) = 35--49). Seventy percent (316/452) of the participants were women; 175/446 (39.2%) were not married, 191/447 (42.7%) had attended primary school only, and more than half 403/449 (89.7%) were unemployed.

3.1. PTB Cases Diagnosed {#sec3.1}
------------------------

Of the 452 PTB suspects, 162 (35.8%) PTB cases were diagnosed. Of those diagnosed with PTB, 40 (24.7%) were diagnosed on the basis of sputum smear positivity, 84 (51.9%) through positive sputum culture, and 38 (23.5%) through chest radiograph.

3.2. Outcomes of PTB Treatment {#sec3.2}
------------------------------

Out of the 162 patients diagnosed with PTB and started on TB treatment, 86 (53.1%) completed treatment, 14 (8.6%) died, 34 (21.0%) were lost to follow up, and 28 (17.3%) were still on treatment at time of data extraction.

3.3. Delay in Diagnosis of PTB {#sec3.3}
------------------------------

The median delay from presentation with PTB symptoms to PTB diagnosis was 55 days (IQR = 20--302). Delay in diagnosis of PTB of more than 56 days was observed among 78 (48.2%) of the 162 patients diagnosed with PTB. The overall delay was 57 to 86 days in 27 (34.6%), 87 to 223 days in 26 (33.3%), and \>236 days in 25 (32.1%) of the patients diagnosed with PTB. The diagnosis was made by clinical history plus chest X-ray for 19 of the 78 (24.7%) and by sputum smear microscopy for 12 (15.4%) The majority of patients with diagnostic delay had their diagnosis made by sputum culture 47/78 (60.3%) ([Table 2](#tab2){ref-type="table"}).

3.4. Factors Associated with TB Diagnosis Delay {#sec3.4}
-----------------------------------------------

Univariate analysis showed patient\'s age (*P* = 0.006), method of TB diagnosis (*P* = 0.025), detectable HIV viral load (*P* = 0.025), and ART use at the time of PTB diagnosis (*P* ≤ 0.001), to be significantly associated with TB diagnosis delay ([Table 3](#tab3){ref-type="table"}). Age, viral load and ART use at the time of PTB diagnosis remained statistically significant in the multivariate analysis. Patients who were older than 40 years had a 1.57 times greater risk of TB diagnostic delay than those aged 18--40 years. The risk of TB diagnostic delay was 1.89 times greater in those with HIV viral load ≥400 copies/mL than patients with HIV viral load ≤400 copies/mL; however the observed association was not statistically significant *P* = 0.06. Those who were on ART at the time of PTB diagnosis were 51% less likely to have experienced diagnostic delay than those who were not on ART ([Table 4](#tab4){ref-type="table"}).

4. Discussion {#sec4}
=============

A large proportion of PTB patients experienced diagnostic delays of greater than 56 days. These findings have important implications for informing current Stop-TB efforts aimed at reducing global TB incidence and mortality. TB diagnosis delay was associated with viral load ≥400 copies/mL. Delayed detection leads to patients presenting with advanced TB which promotes HIV/AIDS disease progression by accelerating viral multiplication \[[@B13]\].

TB diagnostic delay was significantly associated with patient\'s age. Older patients (\>40 years) were at a much higher risk of TB diagnostic delay compared with those younger than 40 years. This is likely to be due to coexisting medical conditions in the elderly persons such as heart diseases and chronic chest problems, all of which may contribute to the difficulty of diagnosing TB and can thus result in delayed diagnosis and treatment \[[@B14], [@B15]\].

The majority of patients with diagnostic delay in this study (60.3%) were diagnosed with PTB by sputum culture. This may be because the study was conducted among HIV-infected patients, and studies have reported reduced diagnostic sensitivity of sputum smears and chest radiography in HIV infected patients \[[@B7]\]. Given the high percentage of patients diagnosed by TB culture, these findings support the practice of regular sputum culture tests to confirm sputum negative smears in ART clinics. Those who were not on ART at the time of PTB diagnosis were more likely to have delayed diagnosis than those who were on ART. ART unmasks TB in HIV-infected patients with subclinical disease making it easier to detect and diagnose \[[@B10]\].

There are several factors that have been reported from previous studies that influences delay in TB diagnosis. These could be patient, clinician, or health system related. Patient-related factors include choice of health care provider, stigma, alcoholism, substance abuse, general state of poor health, tobacco smoking, and chronic cough with blood-stained sputum \[[@B16]--[@B26]\]. Clinician-related factors include: poor training of clinical personnel in TB diagnosis, low level of TB awareness among private practitioners, and lack of knowledge of TB diagnosis among traditional healers \[[@B20], [@B22], [@B24]--[@B29]\]. Health system factors that play a role in delayed TB diagnosis include lack of diagnostic facilities and low access to health care services \[[@B26], [@B30]\].

High viral load is a clinical indicator of declining immunological function of an HIV-infected individual which makes them to be at higher risk of developing active TB. In this era of ongoing HIV epidemic, diagnosis and clinical management of active TB poses a major challenge in patients with dual infection \[[@B31]\]. Due to immunosuppression, there is lack of pulmonary cavitations resulting in low bacillary concentration in sputum giving rise to high rate of negative sputum smear for AFB as well as negative chest radiographic findings. This has led to an over reliance of TB diagnosis through sputum culture which is an expensive and slow diagnostic method \[[@B32], [@B33]\]. This could be the reason why our study showed that a positive relationship exists between diagnostic delay and decline in immune function (viral load \>400 copies/mL).

In considering the findings of this study it is important to bear in mind the following limitations: firstly, as this cohort was recruited from an ART clinic, they may have some differences in characteristics to those participants in hospitals, public health clinics, and the general community. Secondly, the study population did not include PTB suspects who were younger than 18 years, and 85 patients were excluded due to missing medical records. It is possible that some in both groups had active TB. Thirdly, accuracy of interpretation of routinely offered TB diagnostic tests (sputum smear and chest radiographs) depends on the skills and experience of the attending clinician. Interpretation of these tests is often subjective and prone to error; hence some of the results might have been incorrect. Fourthly, some patients in this cohort 42/630 (6.7%) did not return their sputum jars (lost to follow-up) and, therefore, were not investigated for AFB. It is possible that some of these patients had TB or had died of TB. Lastly we did not have data documenting the duration of TB symptoms prior to presenting at a health facility, therefore we would not know length of diagnosis delay attributed to TB patient\'s health seeking behaviour. The exclusion of patients who were lost-to-follow-up and the definition of delay from presentation at health system, rather than start of symptoms, make these findings conservative as the true proportion of patients experiencing diagnosis delays would be higher than what has been reported in this study.

5. Conclusion {#sec5}
=============

The diagnostic delays for PTB demonstrated in this study, as well as the difficulty of diagnosing TB in HIV-infected patients, point to the need for improved screening of TB suspects in ART clinics. Novel TB diagnostic methods such as Gene-Xpert, which are rapid, highly sensitive, and specific, should be promoted in primary health care facilities in order to ensure the timely diagnosis of PTB.

M. Moshabela, R. Zulliger, and P. Nyasulu conceived and designed the study. R. Boniface undertook the data collection and statistical analysis and wrote the first draft of the manuscript. All authors contributed in intellectual content and approved the final manuscript.

The authors have no conflict of interest to declare.

The authors would like to thank all the staff of Rixile HIV clinic and the management of Tintswalo Hospital for their cooperation. The contribution of Ilona Sips in the draft of the paper is greatly appreciated. This study was supported by Rural AIDS and Development Action Research (RADAR), School of Public Health, University of Witwatersrand.
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###### 

Socioeconomic characteristics of study participants.

  Characteristic                        N     (%)
  ------------------------------------- ----- -------
  Marital status                              
   Divorced                             81    18.2
   Married                              131   29.4
   Never married                        175   39.2
   Widowed                              59    13.2
  Total                                 446   100.0
  Education level                             
   No education                         90    20.1
   Primary                              191   42.8
   Secondary                            152   34.0
   Tertiary                             14    3.1
  Total                                 447   100.0
  Occupation status                           
   Salaried worker                      46    10.3
   Unemployed and willing to work       142   31.6
   Unemployed and not willing to work   261   58.1
  Total                                 449   100.0
  Cigarette smoker                            
   No                                   359   80.7
   Yes                                  86    19.3
  Total                                 445   100.0
  Alcohol drinker                             
   No                                   355   79.9
   Yes                                  89    20.1
  Total                                 444   100.0
  Main material walls of house                
   Block cement                         229   51.0
   Brick                                115   25.6
   Mud                                  105   23.4
  Total                                 449   100.0
  People in households                        
   1 to 5                               239   53.1
   6 to 10                              187   41.6
   \>10                                 24    5.3
  Total                                 450   100.0

N: number of study participants in each variable.

###### 

Diagnosis delay duration by method of diagnosis.

  Method of TB diagnosis             57 to 86 days delay ^∗∗^N (%)   87 to 236 days delay ^∗∗^N (%)   \>236 days delay ^∗∗^N (%)   Total Number (%)   *P* value
  ---------------------------------- ------------------------------- -------------------------------- ---------------------------- ------------------ -----------
  Clinical history and chest X-ray   4 (15.3)                        5 (19.2)                         10 (40)                      19 (24.7)          0.016
  Sputum smear positive              3 (11.5)                        2 (7.7)                          7 (28)                       12 (15.6)          
  Sputum culture                     20 (74.1)                       19 (73.1)                        8 (32)                       47 (60.3)          
  Total                              27 (100)                        26 (100)                         25 (100)                     78 (100)           

^∗∗^N: number of TB patients diagnosed within each time duration.

###### 

Comparison of sociodemographic and clinical factors of participants with TB diagnosis delay.

  Characteristic                        Diagnosis delay number (%)   No delay number (%)   *P* value
  ------------------------------------- ---------------------------- --------------------- ------------
  Patient age                                                                              
   18 to 40 years                       33 (42.9)                    54 (64.3)             0.006^∗∗^
   \>40 years                           44 (57.1)                    30 (35.7)             
  Sex                                                                                      
   Female                               49 (62.9)                    58 (69.0)             0.403
   Male                                 29 (37.1)                    26 (31.0)             
  Marital status                                                                           
   Divorced                             13 (16.9)                    13 (15.4)             0.592
   Married                              25 (32.5)                    21 (25.0)             
   Never married                        27 (35.1)                    38 (45.2)             
   Widowed                              12 (15.5)                    12 (14.3)             
  Occupation status                                                                        
   Salaried worker                      9 (11.7)                     7 (8.3)               0.538
   Unemployed and willing to work       21 (27.3)                    29 (34.5)             
   Unemployed and not willing to work   47 (61.0)                    48 (57.2)             
  Smoke cigarette                                                                          
   No                                   57 (74.0)                    66 (78.6)             0.410
   Yes                                  20 (26.0)                    18 (21.4)             
  Alcohol drinking                                                                         
   No                                   57 (74.0)                    65 (79.3)             0.434
   Yes                                  20 (26.0)                    17 (20.7)             
  Education level                                                                          
   No education                         16 (20.8)                    14 (16.7)             0.320
   Primary                              37 (48.0)                    33 (39.2)             
   Secondary                            23 (29.9)                    33 (39.3)             
   Tertiary                             1 (1.3)                      4 (4.8)               
  Main material walls of house                                                             
   Block cement                         38 (49.3)                    47 (56.0)             0.377
   Brick                                19 (24.7)                    22 (26.1)             
   Mud                                  20 (26.0)                    15 (17.9)             
  Method of TB diagnosis                                                                   
   Clinical history and CXR             19 (24.7)                    19 (22.9)             0.025^∗∗^
   Sputum AFB                           12 (15.6)                    28 (33.7)             
   Sputum culture                       46 (59.7)                    36 (43.4)             
  WHO-HIV clinical stage                                                                   
   1                                    2 (3.6)                      2 (2.9)               1.000
   2                                    9 (16.4)                     16 (23.5)             
   3                                    42 (76.4)                    44 (64.8)             
   4                                    2 (3.6)                      6 (8.8)               
  CD4 count (cells/mm^3^)                                                                  
   \<50                                 4 (6.9)                      1 (1.8)               0.193
   50--200                              15 (25.9)                    10 (17.9)             
   \>200                                39 (67.2)                    45 (80.3)             
  Viral load (copies/mL)                                                                   
   ≤400                                 31 (60.8)                    39 (81.3)             0.025^∗∗^
   \>400                                20 (39.2)                    9 (18.7)              
  BMI (Kg/m^2^)                                                                            
   Underweight                          16 (25.4)                    15 (22.4)             0.828
   Normal weight                        34 (53.9)                    38 (56.7)             
   Overweight                           12 (19.0)                    11 (16.4)             
   Obese                                1 (1.5)                      3 (4.5)               
  ART use at PTB diagnosis                                                                 
   No                                   38 (50.0)                    62 (77.5)             ≤0.001^∗∗^
   Yes                                  38 (50.0)                    18 (22.5)             
  TB treatment outcome                                                                     
   Completed treatment                  41 (52.5)                    45 (53.6)             0.640
   Died                                 7 (9.1)                      7 (8.3)               
   Lost to follow up                    14 (17.9)                    20 (23.8)             
   Still on treatment                   16 (20.5)                    12 (14.3)             

^∗∗^ *P* value ≤ 0.05.

###### 

Univariate and multivariate Cox proportional hazards regression analysis.

  Characteristic             Univariate HR (95% CI)   *P*-value   Multivariate HR (95% CI)   *P* value
  -------------------------- ------------------------ ----------- -------------------------- -----------
  Patient age                                                                                
   18 to 40 years            1                                    1                          
   \>40 years                1.8 (0.53--1.32)         0.05        1.57 (0.25--0.90)          0.02
  Sex                                                                                        
   Female                    1                                                               
   Male                      1.26 (0.79--2.03)        0.33        ---                        ---
  Education level                                                                            
   No education              1                                                               
   Primary                   2.62 (1.28--5.34)        0.25                                   
   Secondary                 7.09 (0.87--7.56)        0.17                                   
   Tertiary                  1.54 (0.79--2.95)        0.19                                   
  Method of TB diagnosis                                                                     
   History and CXR           1                                                               
   Smear positive            0.83 (0.48--2.14)        0.95        ---                        ---
   Sputum culture positive   2.09 (1.19--3.65)        0.09                                   
  Viral load (copies/mL)                                                                     
   \<400                     1                                    1                          
   \>400                     2.3 (0.87--1.56)         0.07        1.89 (0.74--1.63)          0.06
  CD4 Count (cells/mm^3^)                                                                    
   \<50                      1                                                               
   50--200                   0.56 (0.18--1.72)        0.31        ---                        ---
   \>200                     0.64 (0.20--1.64)        0.42                                   
  ART use at PTB diagnosis                                                                   
   No                        1                                    1                          
   Yes                       0.82 (1.05--1.3)         0.04        0.49 (0.36--0.97)          0.04
  TB treatment outcome                                                                       
   Completed treatment       1                                                               
   Died                      2.42 (1.07--5.47)        0.03        ---                        ---
   Lost to follow-up         0.92 (0.49--1.73)        0.81                                   
   Still on treatment        0.79 (0.43--1.46)        0.45                                   

HR: hazard ratio; CI: confidence interval.
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